CBP-174 / Suzhou Connect Biopharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CBP-174 / Suzhou Connect Biopharma
NCT04811469: Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults

Completed
1
74
RoW
CBP-174, Placebo
Connect Biopharma Australia Pty Ltd
Healthy Adult Subjects
05/22
05/22

Download Options